SCHEMBL31456012

SCHEMBL31456012

CCCc1cc(OC)c(C=O)cc1Br

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.50
KDM4E B2RXH2 1/20 0.50
TSHR P16473 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
PRKDC P78527 1/20 0.50
SMN1; SMN2 Q16637 2/20 0.46
HTR2A P28223 2/20 0.45
LMNA P02545 3/20 0.45
HPGD P15428 2/20 0.45
HMGCR P04035 2/20 0.45
L3MBTL1 Q9Y468 2/20 0.42
ERN1 O75460 1/20 0.41
TAAR1 Q96RJ0 2/20 0.39
HTR2C P28335 1/20 0.39
MAPT P10636 2/20 0.39
CYP1A2 P05177 1/20 0.37
CYP2C19 P33261 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31456177 0.91 PRKDC (0.47) ALDH1A1KDM4ETSHRTDP1PRKDC
SCHEMBL31456113 0.89 PRKDC (0.46) ALDH1A1KDM4ETSHRTDP1PRKDC
SCHEMBL31456110 0.88 HTR2A (0.46) ALDH1A1KDM4ETSHRTDP1PRKDC
SCHEMBL12831232 0.85 ALDH1A1 (0.60) ALDH1A1KDM4ETSHRTDP1PRKDC
SCHEMBL28375968 0.82 ALDH1A1 (0.52) ALDH1A1KDM4ETSHRTDP1PRKDC
SCHEMBL3469319 0.81 HMGCR (0.60) SMN1; SMN2HTR2AHMGCRTAAR1HTR2C
SCHEMBL31455897 0.81 ALDH1A1 (0.50) ALDH1A1KDM4ETSHRTDP1PRKDC
SCHEMBL16018637 0.80 PRKDC (0.56) ALDH1A1KDM4ETSHRTDP1PRKDC
SCHEMBL24959989 0.79 PRKDC (0.53) ALDH1A1KDM4ETSHRTDP1PRKDC
SCHEMBL6375342 0.79 HTR2A (0.57) SMN1; SMN2HTR2AHMGCRTAAR1HTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025059373-A1 NOVEL PHENALKYLAMINES AND THEIR USE IN THE TREATMENT OF PSYCHIATRIC DISORDERS GILGAMESH PHARMACEUTICALS, INC. (US) 2025-03-20 WO disclosed